Founded in 2019, 30M Genomics operates in Health Tech offering affordable and accessible genetic diagnostics. The company is based in Hyderabad and employs a multi-disciplinary approach to develop var...
Funding stage:
Undisclosed
Last funding:
06/04/2021
Investors
Employee count:
10
Last 90d
10
Last 90d
Web traffic:
850
850
Last 30d
Last 30d
30M Genomics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders9
Latest Filing Date02 Jan 2025- Funding Events12
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of 30M Genomics
As of 03 January 2025, 30M Genomics's equity is held by 8 shareholders, with the top three being Benet Bosco Dhas, Pavani Pavuluri, and Atal Incubation Centre Centre For Cellular & Molecular Biology.
Benet Bosco Dhas holds the largest stake in 30M Genomics at 36.5% as of 03 January 2025.
As of 03 January 2025, founders collectively hold 72.9% equity in 30M Genomics.
As of 03 January 2025, investors collectively hold 16.8% equity in 30M Genomics.
30M Genomics's ESOP pool stands at 9.6% of total equity as of 03 January 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links